ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor SleepGlobeNewsWire • 02/26/25
Here's Why ResMed (RMD) Could be Great Choice for a Bottom FisherZacks Investment Research • 02/14/25
Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea SolutionsSeeking Alpha • 02/10/25
Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 01/31/25
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/25